Incidence of sudden cardiac death and life-threatening arrhythmias in clinically manifest cardiac sarcoidosis with and without current indications for an implantable …
HK Nordenswan, P Pöyhönen, J Lehtonen, K Ekström… - Circulation, 2022 - Am Heart Assoc
Background: Cardiac sarcoidosis (CS) predisposes to sudden cardiac death (SCD).
Guidelines for implantable cardioverter defibrillators (ICDs) in CS have been issued by the …
Guidelines for implantable cardioverter defibrillators (ICDs) in CS have been issued by the …
[HTML][HTML] Use of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in Asia
N Ueda, T Noda, K Kusano, S Yasuda, T Kurita… - JACC: Asia, 2023 - Elsevier
The effectiveness of primary prevention implantable cardioverter-defibrillators (ICDs) is well
established. However, there are several unsolved problems related to ICD use for primary …
established. However, there are several unsolved problems related to ICD use for primary …
Diagnosis and treatment of cardiac sarcoidosis
A De Bortoli, DH Birnie - Circulation Journal, 2023 - jstage.jst.go.jp
About 5% of sarcoidosis patients develop clinically manifest cardiac features. Cardiac
sarcoidosis (CS) typically presents with conduction abnormalities, ventricular arrhythmias …
sarcoidosis (CS) typically presents with conduction abnormalities, ventricular arrhythmias …
Cardiac oxidative stress: a potential tool for risk stratification in cardiac sarcoidosis
Sarcoidosis is a progressive disease of unclear aetiology with most evidence supporting an
aberrant immune response to an unidentified antigen (s) in genetically predisposed …
aberrant immune response to an unidentified antigen (s) in genetically predisposed …
[HTML][HTML] Toward a Consensus for the Prevention of Sudden Death in Cardiac Sarcoidosis
AH Locke, P Zimetbaum - Clinical Electrophysiology, 2021 - jacc.org
Sarcoidosis remains one of the enigmatic diseases in modern medicine. It is believed to
develop from an exaggerated immune response to as yet to be defined antigens in …
develop from an exaggerated immune response to as yet to be defined antigens in …
[PDF][PDF] Cardiac Sarcoidosis and Giant Cell Myocarditis
HK Nordenswan - helda.helsinki.fi
Cardiac sarcoidosis (CS) is the most fatal organ manifestation of sarcoidosis, although the
clinical course is longer, and the prognosis better than previously thought. 1 Most fatalities …
clinical course is longer, and the prognosis better than previously thought. 1 Most fatalities …
[HTML][HTML] Cardiac involvement in sarcoidosis: Evolving concepts in diagnosis and treatment
JP Lynch III, MC Fishbein, JS Bradfield… - Journal of …, 2021 - organscigroup.us
* Corresponding author: Joseph P Lynch III, MD, The Division of Pulmonary and Critical
Care Medicine, Clinical Immunology, Allergy and Sleep, Department of Medicine, David …
Care Medicine, Clinical Immunology, Allergy and Sleep, Department of Medicine, David …